Multiple Sclerosis After Infectious Mononucleosis
Open Access
- 1 January 2007
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 64 (1) , 72-75
- https://doi.org/10.1001/archneur.64.1.72
Abstract
Despite many years of intensive research, the causes of multiple sclerosis (MS) remain unknown. The prevailing view is that MS is an autoimmune disorder that results from various environmental factors acting in a genetically susceptible host.1 Different lines of evidence have implicated infection with the Epstein-Barr virus (EBV) in the development of MS. Investigations have shown that levels of certain EBV antibodies correlate with MS disease activity2,3 and are predictive of MS risk in apparently healthy individuals.4-6 Because more than 90% of healthy adults are infected with EBV, infection alone is clearly insufficient to cause MS. Age at primary infection and the host's immunological response may be modifiers of the EBV-associated risk of MS. Accordingly, infectious mononucleosis, usually caused by EBV infection in adolescence, has been associated with an increased risk of MS in small cohort studies and, less compellingly, in case-control studies.7 However, the association between mononucleosis and the risk of MS remains poorly characterized with respect to sex and age at and time since mononucleosis. Because such information is pertinent to understanding the association, we assessed the risk of MS in a cohort study of patients diagnosed as having mononucleosis.Keywords
This publication has 16 references indexed in Scilit:
- EBV-associated mononucleosis leads to long-term global deficit in T-cell responsiveness to IL-15Blood, 2006
- Infectious mononucleosis and risk for multiple sclerosis: A meta‐analysisAnnals of Neurology, 2006
- Temporal Relationship Between Elevation of Epstein-Barr Virus Antibody Titers and Initial Onset of Neurological Symptoms in Multiple SclerosisJAMA, 2005
- Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosisJournal of Clinical Investigation, 2005
- An altered immune response to Epstein-Barr virus in multiple sclerosisNeurology, 2004
- Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. Ascherio A, Munger KL, Lennette ET, Spiegelman D, Hernán MA, Olek MJ, Hankinson SE, Hunter DJ. JAMA 2001;286:3083–3088American Journal of Ophthalmology, 2002
- Multiple Sclerosis and Age at Infection with Common VirusesEpidemiology, 2001
- Association between clinical disease activity and Epstein–Barr virus reactivation in MSNeurology, 2000
- Reporting delay and corrected incidence of multiple sclerosisStatistics in Medicine, 1999
- Increased risk of multiple sclerosis after late Epstein-Barr virus infection: a historical prospective studyMultiple Sclerosis Journal, 1995